Canada markets open in 3 hours 24 minutes

Aequus Pharmaceuticals Inc. (AQS.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.06500.0000 (0.00%)
At close: 01:44PM EDT
Full screen
Previous Close0.0650
Open0.0600
Bid0.0600 x 0
Ask0.0700 x 0
Day's Range0.0600 - 0.0650
52 Week Range0.0200 - 0.1600
Volume26,000
Avg. Volume16,113
Market Cap8.621M
Beta (5Y Monthly)0.56
PE Ratio (TTM)N/A
EPS (TTM)-0.0130
Earnings DateJul 01, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.52
  • GlobeNewswire

    Press Release for Early Warning Report Regarding Aequus Pharmaceuticals Inc.

    VANCOUVER, British Columbia, July 23, 2022 (GLOBE NEWSWIRE) -- Doug Janzen, of 2820 – 200 Granville St., Vancouver, BC, V6C 1S4, today announced that on Tuesday, July 19, 2022, he acquired ownership (the “Acquisition”) of 100,000 common shares (“Common Shares”) in the capital of Aequus Pharmaceuticals Inc. (Address: 2820 – 200 Granville St., Vancouver, BC V6C 1S4) (“Aequus”) through the facilities of the TSX Venture Exchange. Mr. Janzen acquired 99,000 Common Shares at a price of $0.07 per Commo

  • CNW Group

    IIROC Trading Resumption - AQS

    Trading resumes in:

  • GlobeNewswire

    Aequus Resumes Trading on TSX Venture Exchange

    VANCOUVER, British Columbia, July 13, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) announces that further to our news release dated July 6, 2022, we will resume trading on the TSX Venture exchange tomorrow, July 14, 2022. Doug Janzen noted that “We will be taking steps to lower the risk of this ever happening again. We are excited about the new Scope products announced last week and plan to have other items to add to our product menu in the coming months.” Forw